Owen Mumford this week announced that it has started building its new production facility in Witney, Oxfordshire in the U.K. Owen Mumford’s new Witney facility will stand as a production site for the company’s recently launched, next-generation auto-injector Aidaptus. The company has decades of experience creating its own drug delivery, blood sampling and rapid diagnostic products…
Moderna sales increase 64 times in Q2
Moderna (NSDQ:MRNA) posted second-quarter results today that beat the overall consensus on Wall Street. The Cambridge, Mass.–based company reported profits of $2.8 billion, or $6.46 per share, on sales of $4.4 billion for the three months ended June 30 for a sales growth of 6,398.51% compared with Q2 2020. Earnings per share were $6.46, 40¢ ahead…
Moderna sales increase 242 times in Q1, says COVID-19 vaccine 96% effective in teens
Moderna (Nasdaq:MRNA) posted first-quarter results today that beat the earnings consensus on Wall Street but slightly missed on revenue estimates. The company reported profits of $1.2 billion, or $2.84 per share, on sales of $1.9 billion for the three months ended March 31, for a sales growth of 24112% compared with Q1 2020. Earnings per…
JanOne selects partner to bottle its PAD drug
JanOne recently announced that it has forged a partnership with a company to bottle and label its JAN101 drug. JanOne said it is preparing its investigational new drug application for FDA submission as a potential treatment for vascular complications caused by COVID-19. The drug is already planned for use in Phase 2b trials as a…